Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keros Therapeutics, Inc. | 5,250 | reported | 04 Jun 2025 | tx 7+60,836 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 10+2,175,000−3,146,241 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 5,250 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 2,186 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 437,413 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 1,281,642 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 750,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 275,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 400,000 | — | deriv |
| 06 Jun 2023 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 10 Feb 2023 | GRANT_AWARD | Kinnate Biopharma Inc. | 750,000 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | Kinnate Biopharma Inc. | 400,000 | 0.00 USD | deriv |
| 01 Jun 2021 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |
| 12 Feb 2021 | GRANT_AWARD | Kinnate Biopharma Inc. | 275,000 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,500 | 0.00 USD | deriv |